closing

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

April 06, 2026 10:53 ET  | Source: Celldex Therapeutics, Inc. HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics,…

3 days ago

NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 30, 2026 /PRNewswire/ -- The New York…

2 weeks ago

Onboarding holds the secret to closing the ‘revolving door’ of hiring in US manufacturing, Talogy research finds.

PITTSBURGH, March 24, 2026 /PRNewswire/ -- As US industrial sectors grapple with persistent labor shortages and high turnover, new research from Talogy,…

2 weeks ago

NYSE Content Update: Xylem to Ring Closing Bell Before World Water Day 2026

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 19, 2026 /PRNewswire/ -- The New York…

3 weeks ago

Singapore’s MetaComp Raises Pre-A+ Round Backed By Alibaba, Closing Total US$35 Million Pre-A Funding in 3 months to Accelerate Asia’s Regulated Web2.5 Pay and Wealth[1] Group-Level Platform

SINGAPORE, March 13, 2026 /PRNewswire/ -- MetaComp Pte. Ltd, Asia's pioneer in unified Web2.5 payments and wealth[1] group-level platform together…

4 weeks ago

AIM ImmunoTech Announces Closing of its Rights Offering

OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or…

1 month ago

3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.

TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in institutional digital asset investment solutions, is pleased…

1 month ago

3iQ Announces Earlier Than Anticipated Closing of Previously Disclosed Transaction with Coincheck Group N.V.

TORONTO, Feb. 24, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in institutional digital asset investment solutions, is pleased…

1 month ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

2 months ago

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

February 20, 2026 09:05 ET  | Source: Ernexa Therapeutics Inc. Live video webcast with Sanjeev Luther, President and Chief Executive…

2 months ago